Effect of acetaminophen (paracetamol) on human osteosarcoma cell line MG63

Acta Pharmacologica Sinica

Volumn 31, Issue 11, 2010, Pages 1495-1499

  Díaz Rodríguez, Lourdes ^a   García Martínez, Olga ^a   Arroyo Morales, Manuel ^a   Rubio Ruiz, Belén ^b   Ruiz, Concepción ^a,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

acetaminophen; MG63; nonsteroidal anti inflammatory drugs; osteosarcoma

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; OSTEOCALCIN; PARACETAMOL;

ANTIGEN PRESENTATION; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN MG63; CELLULAR PARAMETERS; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OSSIFICATION; OSTEOBLAST; OSTEOSARCOMA CELL; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; T LYMPHOCYTE;

ACETAMINOPHEN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGEN PRESENTATION; ANTIGENS, CD80; ANTIGENS, CD86; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; OSTEOBLASTS; OSTEOCALCIN; PHAGOCYTOSIS; T-LYMPHOCYTES;

EID: 78149395673     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.129     Document Type: Article

References (35)

1. Ferreira SH, Nakamura M, Castro M. The hyperalgesic effects of prostaciclin and prostaglandin E2. Prostaglandins 1978; 16: 31-7.
2. Smith WL, Dewitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem 2000; 69: 145-82.
3. E splugues JV, Barrachina MD. Mediadores celulares II. Eicosanoides. Óxido Nítrico y factor activador de plaquetas. In: Flórez J, Armijo JA, Mediavilla A, editors. Farmacología Humana. Barcelona: Masson; 2004. p47-362.
4. Hinz B, Cheremina O, Brunek. Acetaminophen (paracetamol) is a selective cyclooxigenase-2 inhibitor in man. FASEB J 2008; 22: 383-90.
5. Davies M, Anderson K. Clinical pharmacokinetic of diclofenac: therapeutic insights and pitfalls. Clin Pharmacokinet 1997; 33: 184-213.
6. Ho ML, Chang JK, Chuang LY, Hsu HK, Wang GJ. Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem Pharmacol 1999; 58: 983-90.
7. Krischak GD, Augat P, Sorg T, Blakytny R, Kinzl L, Claes L and Beck A. Effects of diclofenac on periosteal callus maturation in osteotomy healing in animal model. Arch Orthop Trauma Surg 2007; 127: 3-9.
8. Garcia-Martinez O, Reyes-Botella C, Aguilera-Castillo O, Vallecillo- Capilla MF, Ruiz C. Antigenic profile of osteoblasts present in human bone tissue sections. Bioscience Rep 2006; 26: 39-43.
9. Reyes-Botella C, Montes MJ, Vallecillo-Capilla MF, Olivares EG, Ruiz C. Expression of molecules involved in antigen presentation and T cell activation (HLA-DR, CD80, CD86, CD44, and CD54) by cultured human osteoblasts. J Periodontol 2000; 71: 614-7.
10. Reyes-Botella C, Montes MJ, Vallecillo-Capilla MF, Olivares EG, Ruiz C. Antigenic phenotype of cultured human osteoblast-like cells. Cell Physiol Biochem 2002; 12; 359-64.
11. Ruiz C, Pérez E, Vallecillo-Capilla MF, Reyes-Botella C. Phagocytosis and allogeneic T cell stimulation by cultured human osteoblastic-like cells. Cell Physiol Biochem 2003; 13: 309-14.
12. Díaz-Rodríguez L, García-Martínez O, Arroyo-Morales M, Reyes- Botella C, Ruiz C. Antigenic phenotype and phagocytic capacity of MG63 osteosarcoma line. Ann N Y Acad Sci 2009; 1173 (Suppl 1): E46-E54.
13. Pérez E, Garcia-Martinez O, Arroyo-Morales M, Reyes-Botella C, Ruiz C. Modulation of antigenic phenotype in cultured human osteoblast-like cells by FGFb, TGFbeta1, PDGF-BB, IL-2, IL-1beta, LPS and IFNgamma. Bioscience Rep 2006; 26: 281-9.
14. Ruiz C, Pérez E, García-Martínez O, Díaz L, Arroyo M, Reyes-Botella C. Expression of cytokins IL-4, IL-12, IL-15, IL-18 y IFN and modulation by different growth factors in cultured human osteoblast-like cells. J Bone Miner Metab 2007; 25: 286-92.
15. Thummel KE, Slattery JT, Ro H, Chien JY, Nelson SD, Lown KE, Watkins PB. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin Pharmacol Ther 2000; 67: 591-9.
16. Prouillet C, Mazičre JC, Mazičre C, Wattel A, Brazier M, Kamel S. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 2004; 67: 1307-13.
17. Nayab SN, Jones FH, Olsen I. Effects of calcium ion implantation on human bone cell interaction with titanium. Biomaterial 2005; 26: 4717-27.
18. Thummel KE, Slattery JT, Ro H, Chien JY, Nelson SD, Lown KE, et al. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin Pharmacol Ther 2000; 67: 591-9.
19. Evans CE, Butcher C. The influence on human osteoblasts in vitro of non-steroidal anti-inflammatory drugs which act on different cyclooxygenase enzymes. J Bone Joint Surg Br 2004; 86: 444-9.
20. Kaspar D, Hedrich CM, Schmidt C, Liedert A, Claes LE, Ignatus AA. Diclofenac inhibits proliferation and matrix formation of osteoblasts cells. Unfallchirurg 2005; 108: 20-4.
21. Chang JK, Wang GJ, Tsai ST, Ho ML. Nonsteroidal anti-inflammatory drug effects on osteoblastic cell cycle, cytotoxicity, and cell death. Connect Tissue Res 2005; 46: 200-10.
22. Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 1997; 57: 2452-9.
23. Agarwal B, Swaroop P, Protiva P, Raj SV, Shirin H, Holt PR. COX-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells. Apoptosis 2003; 8: 649-54.
24. Chang JK, Li CJ, Wu SC, Yeh CH, Chen CH, Fu YC, et al. Effects of antiinflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. Biochem Pharmacol 2007; 74: 1371-82.
25. Chang JK, Li CJ, Liao HJ, Wang CK, Wang GJ, Ho ML. Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts. Toxicology 2009; 258: 148-56.
26. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 2000; 290: 989-92.
27. Maier TJ, Schilling K, Schmidt R, Geisslinger G, Grosch S. Cyclooxygenase- 2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Biochem Pharmacol 2004; 67: 1469-78.
28. Lee KH, Choi EM. Biochanin A stimulates osteoblastic differentiation and inhibits hydrogen peroxide-induced production of inflammatory mediators in MC3T3-E1 cells. Biol Pharm Bull 2005; 28: 1948-53.
29. Aubin JE, Liu F, Malaval L, Gupta AK. Osteoblast and chondroblast differentiation. Bone 1995; 17(Suppl 2): S77-S83.
30. Stanley KT, Vandort C, Motyl C, Endres J, Fox DA. Immunocompetent properties of human osteoblasts: interactions with T lymphocytes. J Bone Miner Res 2006; 21: 29-36.
31. Andreae S, Piras F, Burdin N, Triebel F. Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223). J Immunol 2002; 168: 3874-80.
32. Geissman F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327: 656-61.
33. Barnett JB, Brundage KM. Evaluating macrophages in immunotoxicity testing. Methods Mol Biol 2010; 598: 75-94.
34. Ruiz C, Montes MJ, Abadía-Molina AC, Olivares EG. Phagocytosis by fresh and cultured human decidual stromal cells: opposite effects of interleukin-1 alpha and progesterone. J Reprod Immunol 1997; 33: 15-26.
35. Pretzel D, Pohlers D, Weinert S, Kinne RW. In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage. Arthritis Res Ther 2009; 11: R25.